Table 1.

Direct and indirect costs avoided by the MRSA screening and isolation program

Parameter	Number of colonized patients	Number of Infected patients	Cost per day ($US)	Total cost ($US)
Direct cost
Hospital bill per day for infectious disease patient	14	5a	228	4469b
Hospital bill per day for dermatological patient	162	57a	372	63,277c
Hospital bill per day stay for HIV patient	97	34a	226	36,123d
Total direct cost				103,869
Indirect cost
Productivity loss of infectious disease patient	14	5a	155e	2803
Productivity loss of dermatological patient	162	57a	155e	24,324
Productivity loss of HIV patient	97	34a	155e	19,419
Total indirect cost				50,453

^aThirty-five percent of the colonized patients are assumed to progress to infection

^bBased on four additional hospitalization days and five Infectious disease patients estimated to be progressed to infection

^cBased on three additional hospitalization days and 57Dermatological patients estimated to be progressed to infection

^dBased on four additional hospitalization days and 34HIV patients estimated to be progressed to infection

^eEstimated based on GDP per capita of $US 55,183 [36]